OTC Markets OTCQB - Delayed Quote USD

LadRx Corporation (LADX)

Compare
1.7000
+1.7000
(0.00%)
As of January 24 at 3:00:00 PM EST. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
3,836.2420
3,823.3240
4,560.0040
5,979.9780
6,829.6140
Operating Income
-3,836.2420
-3,823.3240
-4,560.0040
-5,979.9780
-6,829.6140
Net Non Operating Interest Income Expense
57.4150
55.4340
11.6890
16.8220
119.2740
Other Income Expense
1,000.0440
4,168.6350
348.6260
-7,213.0920
10.0710
Pretax Income
-2,778.7830
400.7450
-4,199.6890
-13,176.2480
-6,699.8060
Tax Provision
--
--
--
--
0.8000
Net Income Common Stockholders
-2,778.8290
331.6340
-4,761.9540
-13,348.3310
-6,700.6060
Diluted NI Available to Com Stockholders
-2,778.8290
331.6340
-4,761.9540
-13,348.3310
-6,700.6060
Basic EPS
-5.79
0.68
-0.11
-35.00
-19.00
Diluted EPS
-5.79
0.68
-0.11
-35.00
-19.00
Basic Average Shares
495.1350
488.3920
450.3740
375.8460
346.5130
Diluted Average Shares
495.1350
488.3920
450.3740
375.8460
346.5130
Total Operating Income as Reported
-3,836.2880
-3,823.6260
-4,560.8880
-12,076.9900
-6,829.1510
Total Expenses
3,836.2420
3,823.3240
4,560.0040
5,979.9780
6,829.6140
Net Income from Continuing & Discontinued Operation
-2,778.8290
400.4430
-4,200.5730
-13,176.6630
-6,700.6060
Normalized Income
-3,778.8290
-2,891.6600
-4,551.8140
-13,176.6630
-6,700.6060
Interest Income
57.4150
55.4340
11.6890
16.8220
119.2740
Net Interest Income
57.4150
55.4340
11.6890
16.8220
119.2740
EBIT
-3,836.2420
-3,823.3240
-4,560.0040
-5,979.9780
-6,829.6140
EBITDA
-3,828.4070
-3,811.4890
-4,545.0000
-5,966.0000
-6,800.5770
Reconciled Depreciation
7.5830
11.8340
15.0040
13.9780
29.0370
Net Income from Continuing Operation Net Minority Interest
-2,778.8290
400.4430
-4,200.5730
-13,176.6630
-6,700.6060
Total Unusual Items Excluding Goodwill
1,000.0000
4,167.2190
351.2410
--
--
Total Unusual Items
1,000.0000
4,167.2190
351.2410
--
--
Normalized EBITDA
-4,828.4070
-7,978.7080
-4,896.2410
-5,966.0000
-6,800.5770
Tax Rate for Calcs
--
0.0002
--
--
0.0003
Tax Effect of Unusual Items
--
875.1160
--
--
--
12/31/2020 - 3/29/1989

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

2511.HK HighTide Therapeutics, Inc.
1.170
+5.41%
 
MAAT.PA MaaT Pharma SA
8.00
-0.25%
 
PBLA Panbela Therapeutics, Inc.
0.4201
0.00%
 
IPHA Innate Pharma S.A.
1.8300
+6.38%
 
AKTX Akari Therapeutics, Plc
1.2035
-1.35%
 
MSCL.TO Satellos Bioscience Inc.
0.8800
+1.15%
 
SER Serina Therapeutics, Inc.
4.7800
+1.70%
 
CSCI COSCIENS Biopharma Inc.
2.7693
+3.72%
 
PSTV Plus Therapeutics, Inc.
1.2300
+1.61%
 
NBTX Nanobiotix S.A.
3.4220
+0.06%